LegoChem Biosciences Inc Cash Flow Conversion Efficiency

Latest as of March 2026: -0.093x

LegoChem Biosciences Inc cash flow conversion efficiency. Based on the latest financial reports, LegoChem Biosciences Inc (141080) has a cash flow conversion efficiency ratio of -0.093x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-46.62 Billion ≈ $-31.60 Million USD) by net assets (₩500.52 Billion ≈ $339.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of LegoChem Biosciences Inc (2014–2025)

Cash flow conversion efficiency of LegoChem Biosciences Inc from 2014 to 2025. This chart illustrates how LegoChem Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for LegoChem Biosciences Inc for real-time trading data and today's change.

LegoChem Biosciences Inc Cash Flow Conversion Ratio Explained

LegoChem Biosciences Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

LegoChem Biosciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of LegoChem Biosciences Inc ranked by their cash flow conversion efficiency. Also see how much is LegoChem Biosciences Inc worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Timah Persero Tbk JK:TINS	0.130x
CMST Development Co Ltd SHG:600787	0.045x
NP3 Fastigheter AB ST:NP3	0.016x
Capital Southwest Corporation NASDAQ:CSWC	-0.076x
Soulbrain Co. Ltd KQ:357780	0.047x
Shenzhen MeiG Smart Technology Co Ltd SHE:002881	0.075x
Meridianlink Inc NYSE:MLNK	0.049x
FLEX LNG Ltd NYSE:FLNG	0.014x

Annual Cash Flow Conversion Efficiency for LegoChem Biosciences Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of LegoChem Biosciences Inc from 2014 to 2025. Review 141080 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩541.12 Billion ≈ $366.71 Million	₩-124.53 Billion ≈ $-84.39 Million	-0.230x	-280.65%
2024-12-31	₩616.00 Billion ≈ $417.45 Million	₩78.48 Billion ≈ $53.18 Million	0.127x	+130.34%
2023-12-31	₩148.22 Billion ≈ $100.45 Million	₩-62.24 Billion ≈ $-42.18 Million	-0.420x	-1192.20%
2022-12-31	₩219.60 Billion ≈ $148.82 Million	₩-7.14 Billion ≈ $-4.84 Million	-0.032x	+80.00%
2021-12-31	₩258.77 Billion ≈ $175.37 Million	₩-42.05 Billion ≈ $-28.50 Million	-0.162x	-22.33%
2020-12-31	₩112.13 Billion ≈ $75.99 Million	₩-14.89 Billion ≈ $-10.09 Million	-0.133x	-162.66%
2019-12-31	₩113.75 Billion ≈ $77.09 Million	₩24.11 Billion ≈ $16.34 Million	0.212x	+268.92%
2018-12-31	₩101.66 Billion ≈ $68.90 Million	₩-12.76 Billion ≈ $-8.65 Million	-0.125x	+26.34%
2017-12-31	₩48.21 Billion ≈ $32.67 Million	₩-8.21 Billion ≈ $-5.57 Million	-0.170x	+21.52%
2016-12-31	₩60.06 Billion ≈ $40.70 Million	₩-13.04 Billion ≈ $-8.84 Million	-0.217x	-9.73%
2015-12-31	₩43.18 Billion ≈ $29.26 Million	₩-8.54 Billion ≈ $-5.79 Million	-0.198x	+49.69%
2014-12-31	₩20.04 Billion ≈ $13.58 Million	₩-7.88 Billion ≈ $-5.34 Million	-0.393x	--

About LegoChem Biosciences Inc

KQ:141080 Korea Biotechnology

Market Cap

$1.48 Billion

₩2.18 Trillion KRW

Market Cap Rank

#7002 Global

#161 in Korea

Share Price

₩59900.00

Change (1 day)

-2.92%

52-Week Range

₩59900.00 - ₩213500.00

All Time High

₩213500.00